CHCWM – Cancer & Hematology Centers of West Michigan

LYT-200-2020-01 (PureTech Health LLC)

A Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with Chemotherapy or Anti-PD-1 in Patients with Metastatic Solid Tumors